The gene coding for the RNA subunit of ribonuclease P (RNase P) is essential in all free-living organisms. The RNA subunit, itself, is an enzyme and, from its evolutionary tree, we can infer that it is a very ancient molecule. The specificity of this enzyme is that it cleaves other RNA molecules at the junction of single-stranded and the 5 0 end of double-stranded regions of RNA. One can speculate that this molecule was very useful in an ancient world in cleaving long pieces of RNA, which must have contained hairpin regions in it, into shorter molecules with the capability of different functions from the longer parent. Today, the specificity of the enzyme can be used in designing drug therapies.
INTRODUCTION
Ribonuclease P (RNase P) is an endoribonuclease that cleaves other RNA molecules at the junction between a single-stranded region and the 5 0 end of a doublestranded region. In bacteria, the enzyme is made up of two subunits, a small, basic subunit of molecular weight approximately 14 000, and a large RNA subunit of molecular weight approximately 125 000. The RNA subunit is catalytic and, in vitro, it has all the properties of a true enzyme [1] .
A feature of this enzyme that deserves further study is its properties during evolution. As illustrated in figure 1 , the catalytic role of the RNA subunit by itself varies among bacteria, archaea and eukaryotes. The progression, if it can be called that, decreases by a factor of about a million-fold as we go from bacteria to humans. The number of protein subunits associated with the enzyme, however, increases from one in bacteria [4] to at least 10 in human tissue [5] . Why the proteins either enhance the catalysis of the RNA during evolution, or have properties of the catalyst, which is unlikely from studies of individual proteins from human tissue cells, is not yet understood [6] .
While there is virtually no homology between the proteins from bacteria and other species, there is some correspondence among archaea [5, 7] , yeast [8] and humans as shown in figure 2. These similarities are satisfying and will lead to future studies of the domains of these proteins and their particular functions. One should note that of the archaea proteins, one of them has now been found to be a ribosomal protein that enhances the activity of an RNase P complex considerably. Furthermore, the human protein Rpp29 also enables the catalytic activity of M1 RNA, the RNA subunit of the enzyme from Escherichia coli in human tissue culture cells. Although it was known that M1 RNA functions in human tissue culture cells and interacts with a nuclear protein, until recently the particular protein was not identified (N. Jarrous 2010, personal communication). The nature of the protein sequences and the DNA that encodes them allow one to create a simple evolutionary tree as shown in figure 3 [7] . What is apparent is that the bacteria have branched off from a common ancestor and the archaea and eukaryotes form another branch. It is evident from this tree, and from similar sketches of the RNA subunit, which does maintain a similar form in three-dimensional space, that the enzyme is an ancient structure in the parlance of this particular symposium.
The first substrate analysed for RNase P was a precursor to an amber-suppressing tRNA
Tyr from E. coli [9] as shown in figure 4 . The site of cleavage by the enzyme is indicated by the arrow in figure 4 . Sequence analysis of several other tRNA precursors from E. coli showed that the sequence around the cleavage sites, always the junction between a single-stranded region and a double-stranded region, was not identical within the bacterium. One of the initial problems then was to understand the nature of the enzymatic specificity. This became apparent as more substrates were found in E. coli [10 -12] and through the study of model substrates [13] .
Several more substrates for RNase P are shown in figure 5. All these molecules, named in the legend to figure 5, show the same site of cleavage as in tRNA precursors as indicated by the arrows. They do not have the usual other stems and loops of a tRNA molecule. These results gave support to the general notion that the enzyme recognized the structure of the molecule it was cleaving.
Further data were gathered when large molecules were examined at the restrictive temperature of a thermosensitive mutant in the gene coding for the protein subunit in RNase P. The new molecules were not cleaved by RNase P under restrictive conditions and they were all mRNAs coding for operons [14] . The cleavage sites are indicated by the underlined black lines in figure 6. This conclusion was verified by examining the cleavage of the lac operon mRNA [15] . Indeed, as seen in figure 7 , the sequence between the lacA and lacY genes can be arranged in the familiar structure known to be cleaved by RNase P and this was shown to be the case by experiments in vitro. This result resolved a long-standing problem about the amount of each protein produced under permissive conditions [16] . With the other operons, the amount of each product has not been measured with the intact operon mRNA present. What did this RNase P, as embodied in the RNA subunit of the modern enzyme, do in the ancient world? Speculation allows us to propose a model shown in figure 8 [17] . The model is quite simple, but perhaps important in the generation of RNAs of different sizes that might be enabled to carry out various functions. As is well known, any RNA of considerable size, perhaps 100 nt or longer, is most likely to have hairpin regions in it. If an RNA with RNase P function existed, then it could cleave these longer molecules to make smaller hairpins that could then go on to engage in other capabilities such as riboswitches, other catalysts of metabolic function or hairpins with minimal tRNA properties.
Currently, the ubiquity of RNase P in all free-living cells provides an opportunity to design a possible therapy against any disease for which there is an RNA, or mRNA, that lies as its cause. In making model substrates for RNase P, the gene for precursor tRNA (figure 9) was reduced in size by restriction enzyme digests and then transcribed to give ultimately, when an additional oligonucleotide is added, the complex shown in figure 9b. This is a good substrate for the enzyme. That complex, actually two molecules joined by hydrogen bonds, consists of any target RNA in cells and an 'external guide sequence' (EGS). Providing the EGS can be designed for any RNA of choice and inserted into cells, the target RNA will be cleaved by the resident RNase P and inactivated [18] . This has been carried out with some success as is summarized in table 1. In these cases, the EGS was encoded in a small, synthetic gene in a plasmid that was electroporated into the bacteria [19] . The problem of getting the EGS into different cell types in animals is not trivial. Liposomes that envelop EGSs have been delivered to tissue culture cells with some success [20] but basic peptides covalently attached to morpholino oligonucleotides (PPMO; table 1) have been used recently with very good practical results [21] . The structure shown in figure 10 , provided by AVI BioPharma (Bothell, WA, USA), has enabled the transfection of bacteria to change the phenotype of certain cell types. However, a basic peptide derived from T cells conjugated to morhpolino oligonucleotides is 10 times more successful in terms of the concentrations needed to change phenotypes from drug resistance to drug sensitivity and to kill cells with a gyraseA-targeted mRNA. Viability levels of 10 24 after a 6 h treatment have been achieved in 
